IKS Health IPO Share Allotment Status To Finalise on December 17

Inventurus Knowledge Solutions IPO backed by the Jhunjhunwala family is set to finalise the share allotment status on Tuesday, December 17, 2024. The ₹2,498-crore mainboard IPO closed for bidding on December 16 with strong investor demand. IKS Health IPO was subscribed 52.68 times during the 3-day subscription period, which opened on December 12.
Subscription Breakdown
- Investors across categories applied for 54.6 crore shares against the 1.03 crore shares offered by the company.
- The portion reserved for Non-Institutional Investors was oversubscribed 23.25 times.
- Retail investor demand stood at 14.55 times the shares on offer.
- Institutional investors led the bidding, subscribing to 80.64 times the shares reserved for them.
- The employee segment was subscribed 5.2 times.
Due to the strong subscription numbers, the allotment of shares in the IKS Health IPO is expected to be highly competitive. Investors can check their allotment status online via the official websites of the BSE, NSE, or the IPO registrar, Link Intime India Pvt. Ltd.
Allotment and Listing Details
- Successful bidders will receive their IKS Health shares in their Demat accounts on December 18, 2024.
- Refunds for non-allottees will also be processed on the same day.
- Shares of Inventurus Knowledge Solutions Ltd (IKS Health) are scheduled to be listed on both the NSE and BSE on December 19, 2024.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Dec 17, 2024, 11:18 AM IST
- Augmont Enterprises Share Price: Stock Lists at 21.95% Premium on NSE
- Upcoming IPOs This Week (August 31–September 4, 2026): Purple Style Labs, Deepa Jewellers and Others
- ABH Healthcare IPO Allotment Status
- Hy-Tech Engineers IPO Allotment Status
- Symbiotec Pharmalab IPO Allotment Status


